共 50 条
- [1] A double-blind, randomised, placebo-controlled trial of anti-interleukin-6 (IL-6) receptor monoclonal antibody in rheumatoid arthritis (RA). ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S274 - S274
- [2] Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody - A multicenter, double-blind, placebo-controlled trial ARTHRITIS AND RHEUMATISM, 2004, 50 (06): : 1761 - 1769
- [3] Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis - A randomized, double-blind, placebo-controlled, dose-escalation trial ARTHRITIS AND RHEUMATISM, 2002, 46 (12): : 3143 - 3150
- [5] Safety and efficacy of repetitive treatment with humanized anti-interleukin-6 receptor antibody (MRA) in rheumatoid arthritis (RA). ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S84 - S84
- [6] Anti-interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis -: A randomized, double-blind, placebo-controlled study ARTHRITIS AND RHEUMATISM, 2006, 54 (06): : 1778 - 1785
- [9] Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2011, 3 : 19 - 29